# R33: Levetiracetam in Early Psychosis

> **NCT04317807** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 65 (actual)

## Conditions studied

- Early Psychosis

## Interventions

- **DRUG:** Levetiracetam Pill
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04317807
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-27
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-10
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04317807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04317807, "R33: Levetiracetam in Early Psychosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04317807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*